Attached files
| file | filename |
|---|---|
| 10-K - ELITE PHARMACEUTICALS INC /NV/ | v190023_10k.htm |
| EX-21 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex21.htm |
| EX-31.1 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex31-1.htm |
| EX-32.1 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex32-1.htm |
| EX-23.1 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex23-1.htm |
| EX-32.2 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex32-2.htm |
| EX-31.2 - ELITE PHARMACEUTICALS INC /NV/ | v190023_ex31-2.htm |
ELITE
PHARMACEUTICALS, INC. AND SUBSIDIARIES
Exhibit
23.2
CONSENT
OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We
consent to the incorporation by reference in the following documents of our
report dated June 29, 2009, relating to the consolidated financial statements of
Elite Pharmaceuticals, Inc. and Subsidiaries (which report expresses an
unqualified opinion and includes an explanatory paragraph referring to
uncertainty about the Company’s ability to continue as a going concern),
incorporated by reference in the Annual Report on Form 10-K of the Company for
the year ended March 31, 2010.
Registration
Statement No. 333-163907 on Form S-8 dated December 22, 2009
Registration
Statement No. 333-132140 on From S-8 dated March 1, 2006
Registration
Statement No. 333-118524 on From S-8 dated August 24, 2004
/S/ Rosen
Seymour Shapss Martin & Company LLP
New York,
New York
July 7,
2010